Skip to main content
Tech.euFundingExplorerBeta

AMPLY

AMPLY’s AI drug discovery platform was developed to ensure new generations of antibiotics remain effective against infections.

Total raised
€4.2M
€4,217,026
Funding rounds
3
Investors
12
distinct backers
Active since
2022-09
latest 2025-05

Funding by year

EUR raised per year

Signals

High confidence
Raise-next likelihood48
base rate 44% for Seed
  • In typical raise window
  • Low backer re-investment
Exit likelihood14
base rate 12% (2+ rounds)
  • 3 rounds raised

Timing: in window vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.

Similar companies

same sector or country